SCHEMBL16590867

SCHEMBL16590867

CCC1=CC(Cl)=CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18889787 0.83 AURKA (0.30) —
SCHEMBL17581113 0.77 — —
SCHEMBL1053003 0.77 — —
SCHEMBL20182048 0.77 — —
SCHEMBL6275922 0.75 NOS3 (0.34) —
SCHEMBL6275927 0.75 NOS3 (0.34) —
SCHEMBL15674868 0.74 — —
SCHEMBL15674923 0.74 NOS3 (0.38) —
SCHEMBL14823685 0.73 — —
SCHEMBL16590870 0.70 MPO (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015042243-A1 TRIAZOLOPYRIDINE ETHER DERIVATIVES AND THEIR USE IN NEUROLOGICAL AND PYSCHIATRIC DISORDERS BRISTOL-MYERS SQUIBB COMPANY (US) 2015-03-26 — — WO disclosed
Send feedback